A newspaper�s investigation is focusing new attention on the way some university researchers take money to share early opinions about clinical drug trials they are conducting.
This month, The Seattle Times published articles that detailed the way investment firms tap into medical professors and other doctors involved in drug trials to get advance work on how the trials are going.